ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

Oncology

Reviews and Perspectives for the Practicing Oncologist
Featured Article

Active Surveillance for Prostate Cancer: How to Do It Right

Juan D. Garisto and Laurence Klotz

In this review of active surveillance for favorable-risk prostate cancer, we will discuss the rationality of this approach, the biological evidence for employing active surveillance in Gleason pattern 3 and 4 prostate cancer, patient selection for active surveillance, clinical trial data on active surveillance, and the role of prostate cancer biomarkers and imaging studies for clinical decision making in patients with low-risk disease.

 

May 2017 Table of Contents

Volume 31 | Number 5
REVIEW ARTICLES

Decision Making in the Surgical Management of Invasive Breast Cancer
Lisa A. Newman

Part 1: Lumpectomy, Mastectomy, and Contralateral Prophylactic Mastectomy
Part 2: Expanded Applications for Breast-Conserving Surgery

The Growing Challenge of Young Adults With Colorectal Cancer
Benjamin A. Weinberg, John L. Marshall, and Mohamed E. Salem

Reassessment of Anti-CD20 Therapy in Lymphoid Malignancies: Impact, Limitations, and New Directions
Patrick M. Reagan and Jonathan W. Friedberg

Commentary: The Uncertainties of Rituximab and Related Therapies, 20 Years After Approval

Active Surveillance for Prostate Cancer: How to Do It Right
Juan D. Garisto and Laurence Klotz

Comorbidity Consult

Management Considerations in Cancer Patients With Rheumatoid Arthritis
Richard J. Zogala, Kristina Goutsouliak, and Maria E. Suarez-Almazor

Q&A

With Decades of Perspective, Craig Henderson Observes That Treatment of Breast Cancer Has Come a Long Way

Clinical Quandaries

Gross Hematuria and Suspicious Bladder Lesions in a 52-Year-Old North African Immigrant
Pranav Sharma and Allan Haynes, Jr

Point/Counterpoint

POINT: Is Lymphadenectomy Required in Endometrial Cancer for Adequate Surgical Staging? Sentinel Lymph Node Mapping: A Novel and Promising Approach for Surgical Staging
Francesco Multinu, Jvan Casarin, and Andrea Mariani

COUNTERPOINT: Is Lymphadenectomy Required in Endometrial Cancer for Adequate Surgical Staging? Comprehensive Lymphadenectomy Increases Morbidity and Provides No Survival Benefit in Clinical Stage I Endometrial Cancer
Emma Rossi

Editors-in-Chief

Julie VoseJulie M. Vose, MDUniversity of Nebraska Medical School Omaha, Nebraska
Editor-in-Chief, ONCOLOGY
Nora JanjanNora Janjan, MD, MPSA, MBA Senior Fellow for Healthcare Policy, National Center for Policy Analysis
Editor-in-Chief, ONCOLOGY
William C. Wood, MDWilliam C. Wood, MD Department of Surgery, Emory University School of Medicine, Atlanta, Georgia
Editor-in-Chief, ONCOLOGY
Nancy E. Davidson, MDNancy E. Davidson, MD University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania UPMC CancerCenter, Pittsburgh
Editor-in-Chief, ONCOLOGY

 

By clicking Accept, you agree to become a member of the UBM Medica Community.